
American Well NYSE: AMWL, known as Amwell, reported third-quarter 2026 revenue above its guidance range and narrowed its adjusted EBITDA loss as stronger visit volumes and cost controls helped support its target of reaching positive adjusted EBITDA and operating cash flow in the fourth quarter.










